v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (16,189,200) $ (5,952,465)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation from asset purchase 10,000
Depreciation expense 47,882 68,450
Amortization of intangible assets 834 833
Amortization of debt discount - note payable 24,687 200,284
Change in fair value of derivative liability 11,800,798 (13,145)
Change in fair value of Evofem warrants (25,004)
Impairment of fixed assets 32,275
Changes in operating assets and liabilities:    
Accounts receivable (11,974) 1,317
Prepaid expenses 294,310 (59,237)
Deposits (92,174)
Inventory 9,289 2,188
Accounts payable and accrued expenses (562,609) (5,879,446)
Net cash used in operating activities (4,578,712) (11,713,395)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of fixed assets (10,379)
Net cash used in investing activities (10,379)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from notes and convertible notes payable, net of offering costs 2,855,000
Repayments of note payable, related party (115,000)
Repayments of note payable (1,428,921) (2,778,978)
Common stock, preferred stock, and warrants issued for cash, net of issuance costs 603,261 20,169,072
Cash from subscription receivable 1,108,751
Redemptions of A-1 preferred stock (369,996)
Redemptions of C-1 preferred stock (7,027,065)
Net cash provided by financing activities 1,659,344 11,356,780
NET DECREASE IN CASH (2,929,747) (356,615)
CASH AT BEGINNING OF PERIOD 3,198,599 833,031
CASH AT END OF PERIOD 268,852 476,416
Supplemental cash flow information:    
Cash paid for income taxes
Cash paid for interest 152,965 1,264,504
NONCASH INVESTING AND FINANCING ACTIVITIES:    
Derivative liability from conversion feature on warrants 13,736,777
Derivative liability from conversion feature on preferred stock 9,913,157
ELOC payable 630,105
Series C-1 redemption payable 1,247,367
ELOC commitment fee stock payable 2,250,000
Reclassification of series A-1 preferred shares to liabilities 369,996
Conversion of Series A-1 to common stock $ 20,000,000